Loading...
Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy o...
Na minha lista:
| Udgivet i: | Urol Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4909527/ https://ncbi.nlm.nih.gov/pubmed/27335798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2016.04.012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|